Le livre est actuellement en rupture de stock
En savoir plus sur le livre
From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M& A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M& A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.
Achat du livre
Pharma m&a versus alliances and its underlying value drivers, Heiko Schon
- Langue
- Année de publication
- 2015
- product-detail.submit-box.info.binding
- (rigide)
Nous vous informerons par e-mail dès que nous l’aurons retrouvé.
Modes de paiement
Personne n'a encore évalué .